Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

The study was retracted.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Baricitinib was effective in treating both early and late onset alopecia areata.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Platelet-Rich Plasma treatment helps hair regrowth in people with mild Alopecia Areata, improving their quality of life with minimal side effects.